Ferguson Wellman Capital Management Inc. trimmed its holdings in shares of Metlife Inc (NYSE:MET) by 1.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 270,338 shares of the financial services provider’s stock after selling 4,601 shares during the quarter. Ferguson Wellman Capital Management Inc.’s holdings in Metlife were worth $13,779,000 as of its most recent SEC filing.
Other hedge funds have also modified their holdings of the company. Telos Capital Management Inc. boosted its stake in Metlife by 11.9% in the fourth quarter. Telos Capital Management Inc. now owns 49,446 shares of the financial services provider’s stock valued at $2,520,000 after acquiring an additional 5,275 shares in the last quarter. First Midwest Bank Trust Division boosted its stake in Metlife by 48.1% in the fourth quarter. First Midwest Bank Trust Division now owns 8,880 shares of the financial services provider’s stock valued at $453,000 after acquiring an additional 2,883 shares in the last quarter. Summit X LLC acquired a new stake in Metlife in the fourth quarter valued at approximately $2,298,000. McKinley Carter Wealth Services Inc. boosted its stake in Metlife by 8.5% in the fourth quarter. McKinley Carter Wealth Services Inc. now owns 15,391 shares of the financial services provider’s stock valued at $784,000 after acquiring an additional 1,206 shares in the last quarter. Finally, J.W. Cole Advisors Inc. acquired a new stake in Metlife in the fourth quarter valued at approximately $278,000. 74.47% of the stock is currently owned by institutional investors.
NYSE:MET opened at $51.80 on Friday. Metlife Inc has a 12 month low of $41.41 and a 12 month high of $52.76. The firm has a fifty day simple moving average of $51.15 and a 200-day simple moving average of $48.42. The company has a current ratio of 0.15, a quick ratio of 0.15 and a debt-to-equity ratio of 0.21. The company has a market capitalization of $47.73 billion, a P/E ratio of 6.90, a PEG ratio of 1.00 and a beta of 1.13.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 13th. Stockholders of record on Tuesday, February 4th will be paid a dividend of $0.44 per share. The ex-dividend date is Monday, February 3rd. This represents a $1.76 annualized dividend and a dividend yield of 3.40%. Metlife’s payout ratio is currently 32.65%.
Several equities research analysts have weighed in on the stock. Zacks Investment Research upgraded shares of Metlife from a “sell” rating to a “hold” rating and set a $52.00 target price for the company in a research note on Monday, December 9th. ValuEngine upgraded shares of Metlife from a “strong sell” rating to a “sell” rating in a research note on Saturday, December 21st. Wells Fargo & Co restated a “buy” rating on shares of Metlife in a research note on Monday, January 6th. B. Riley restated a “neutral” rating on shares of Metlife in a research note on Tuesday, October 15th. Finally, Morgan Stanley upgraded shares of Metlife from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $55.00 to $60.00 in a research note on Tuesday, January 7th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and four have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $51.13.
MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.
Featured Article: Inverted Yield Curve
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.